NuvOx Pharma
✓ Verified ManufacturerAbout
NuvOx Pharma is a clinical-stage biotechnology company based in Tucson, Arizona, specializing in the development of innovative oxygen therapeutics for life-threatening diseases where hypoxia plays a critical role. Founded in 2008, the company has established itself as a pioneer in oxygen therapeutic technology with its proprietary NanO₂ platform, representing a first-in-class approach to treating conditions involving oxygen deficiency. The company operates a state-of-the-art GMP manufacturing facility at their Tucson headquarters, enabling in-house production of their injectable pharmaceutical products. NuvOx Pharma has demonstrated significant clinical progress through over 30 preclinical animal studies spanning seven different therapeutic indications, with compelling results from Phase Ib/IIa clinical trials in stroke and oncology applications. Currently, NuvOx Pharma is conducting multiple clinical programs, including a Phase IIb randomized, placebo-controlled trial enrolling 87 glioblastoma patients utilizing their oxygen therapeutic as a radiosensitizer. The company is also advancing trials for respiratory conditions, including studies for patients with mild respiratory distress and acute hypoxemic respiratory failure. Led by experienced pharmaceutical executives and inventors holding over 120 issued patents, NuvOx Pharma combines scientific innovation with robust manufacturing capabilities to address critical unmet medical needs in oncology, neurology, and respiratory medicine.